¼¼°èÀÇ ¼ÒÈ­±â ³»½Ã°æ ±â±â ½ÃÀå
Gastrointestinal (GI) Endoscopy Devices
»óǰÄÚµå : 1514070
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 169 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,009,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,027,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¼ÒÈ­±â ³»½Ã°æ ±â±â ½ÃÀåÀº 2030³â±îÁö 499¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2023³â 352¾ï ´Þ·¯·Î Æò°¡µÈ ¼¼°èÀÇ ¼ÒÈ­±â ³»½Ã°æ ±â±â ½ÃÀåÀº 2030³â¿¡´Â 499¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGRÀº 5.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ³»½Ã°æÀû ¿ªÇ༺ ´ã°ü ÃéÀå°ü Á¶¿µ ÀåÄ¡(ERCP)´Â CAGR 5.3%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 255¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ĸ½¶ ³»½Ã°æ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 5.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 95¾ï ´Þ·¯, Áß±¹Àº CAGR 8.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼ÒÈ­±â ³»½Ã°æ ±â±â ½ÃÀåÀº 2023³â 95¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 109¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGRÀº 8.6%·Î Àü¸ÁµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.6%¿Í 4.2%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¼ÒÈ­±â ³»½Ã°æ ±â±â ½ÃÀå-ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

¼ÒÈ­±â ³»½Ã°æ ±â±â´Â ÀÇ·á ºÐ¾ß¿¡¼­ ´Ù¾çÇÑ ¼ÒÈ­±â°è ÁúȯÀÇ Áø´Ü°ú Ä¡·á¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Àåºñ¿¡´Â ¿¬¼º ³»½Ã°æ, °íÇØ»óµµ ½Ã°¢È­ ½Ã½ºÅÛ, »ý°Ë Áý°Ô, Æú¸³ ÀýÁ¦¿ë ½º³×¾î, ÁöÇ÷ ÀåÄ¡ µîÀÇ ¾×¼¼¼­¸®¸¦ Æ÷ÇÔÇÑ ±¤¹üÀ§ÇÑ Àåºñ°¡ Æ÷ÇԵ˴ϴÙ. ¼ÒÈ­±â ³»½Ã°æ °Ë»ç´Â ½Äµµ, À§, Àå, ´ëÀåÀÇ »ó¼¼ÇÑ ½Ç½Ã°£ À̹ÌÁö¿Í ºñµð¿À¸¦ Á¦°øÇÏ¿© ¼ÒÈ­°üÀÇ ³·Àº ħ½À °Ë»ç¸¦ ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ÃÖ±Ù ±â¼ú µ¿ÇâÀº ÀÌ·¯ÇÑ Àåºñ¸¦ Å©°Ô °­È­ÇÏ°í ¼ÒÈ­°ü ¾Ï, ±Ë¾ç, ¿°Áõ¼º Àå Áúȯ°ú °°Àº Áø´Ü Á¤È®µµ¸¦ Çâ»ó½ÃŰ´Â º¸´Ù Á¤±³Çϰí À¯¿¬ÇÏ¸ç ¼ÒÇüÈ­ µÈ ³»½Ã°æ °³¹ß·Î À̾îÁ³½À´Ï´Ù. °Ô´Ù°¡ ÀΰøÁö´É(AI)¿¡ ÀÇÇÑ È­»ó ÇØ¼®, ³»½Ã°æÀÇ Á¶ÀÛ¼ºÀÇ Çâ»ó, È­»ó ó¸® ´É·ÂÀÇ Çâ»óÀ̶ó°í ÇÏ´Â ±â¼ú Çõ½ÅÀº ³»½Ã°æ °Ë»ç¿¡ Çõ¸íÀ» °¡Á®, º¸´Ù È¿À²ÀûÀ̰í Àúħ½ÀÀûÀÎ °Ë»ç°¡ °¡´ÉÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸´Â GI ³»½Ã°æ ÀåºñÀÇ Áø´Ü ´É·ÂÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚÀÇ Æí¾ÈÇÔ°ú °á°úµµ °³¼±Çϰí ÀÖ½À´Ï´Ù.

¼ÒÈ­±â ³»½Ã°æ °Ë»ç Àåºñ ½ÃÀåÀº ¼ÒÈ­±â ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Á¶±â Áø´Ü ±â¼úÀÇ Ã¤Åà Ȯ´ë·Î Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¼ÒÈ­°ü ÁúȯÀº ¼¼°èÀûÀ¸·Î °¡Àå ÈçÇÑ °Ç°­ ¹®Á¦ Áß ÇϳªÀÌ¸ç ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡¸ç ¸¹Àº ¾çÀÇ °Ç°­ °ü¸® ºñ¿ëÀ» ºÎ°úÇÕ´Ï´Ù. ¼¼°èÀÇ °í·ÉÈ­¿¡ ÀÇÇØ ÀÌ·¯ÇÑ ÁúȯÀº ƯÈ÷ ¿µÇâÀ» ¹Þ±â ½¬¿öÁö°í ÀÖ¾î, ±× °á°ú, ³»½Ã°æ¿¡ ÀÇÇÑ Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ȯÀÚ¿Í °Ç°­ °ü¸® Á¦°ø¾÷ü »çÀÌ¿¡ Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ Àνİú ¼ö¿ëÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼ÒÈ­±â ³»½Ã°æ ÀåºñÀÇ Ã¤ÅÃÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. º´¿ø ¹× Áø·á¼Ò¸¦ Æ÷ÇÔÇÑ °Ç°­ °ü¸® ½Ã¼³Àº ȯÀÚ °ü¸®¸¦ °­È­Çϰí Áø´Ü Á¤È®µµ¸¦ ³ôÀ̰í ÀÔ¿ø ±â°£À» ´ÜÃàÇϱâ À§ÇØ ÃÖ÷´Ü ³»½Ã°æ Àåºñ¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÀÇ·á Á¦°ø¾÷ü°¡ ³»½Ã°æ ¼­ºñ½º¸¦ È®´ëÇÏ´Â Àμ¾Æ¼ºê°¡ µÇ´Â ¸¹Àº Áö¿ª¿¡¼­ À¯¸®ÇÑ »óȯ Á¤Ã¥¿¡ ÀÇÇØ ´õ¿í µÞ¹ÞħµË´Ï´Ù. ±× °á°ú, ¼¼°èÀÇ ÀÓ»ó ÇöÀå¿¡¼­ ¼±ÁøÀûÀÎ ¼ÒÈ­±â ³»½Ã°æ ±â±âÀÇ ÀÌ¿ëÀÌ ÇöÀúÇÏ°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

GI ³»½Ã°æ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú Áøº¸, ¼ÒÈ­±â ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, ³·Àº ħ½À óġ¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀº ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ³»½Ã°æ ¿µ»ó Áø´Ü¿¡¼­ ÀΰøÁö´ÉÀÇ ÅëÇÕÀº Áø´Ü Á¤È®µµ¿Í ¼Óµµ¸¦ Å©°Ô Çâ»ó½ÃÄÑ º¸´Ù Á¤È®ÇÑ ÀÌ»ó °ËÃâÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÏȸ¿ë ³»½Ã°æÀÇ °³¹ßµµ Å« Áøº¸À̸ç, ±³Â÷ ¿À¿°À̳ª °¨¿°ÀÇ ¸®½ºÅ©¸¦ Àú°¨ÇØ, ÀÓ»ó ÇöÀå¿¡¼­ÀÇ Ã¤¿ëÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ´ëÀå¾Ï°ú ±âŸ ¼ÒÈ­±â ¾ÏÀÇ À¯º´·ü Áõ°¡´Â Á¤±âÀûÀÎ °ËÁøÀÇ Çʿ伺À» °­Á¶ÇÏ°í ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½Ä»ýȰÀÇ È¥¶õÀ̳ª ¾ÉÀº »îÀÇ »ýȰ°ú °°Àº ¶óÀÌÇÁ ½ºÅ¸ÀÏÀÇ º¯È­°¡ ¼ÒÈ­±â ÁúȯÀÇ ±ÞÁõÀ¸·Î À̾îÁ® ³»½Ã°æ °Ë»ç ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë ¹× ÀÇ·áºñ Áõ°¡´Â ¼ÒÈ­±â ³»½Ã°æ Àåºñ ½ÃÀå¿¡ »õ·Î¿î ¼ºÀå ±âȸ¸¦ °¡Á®¿Ô½À´Ï´Ù. ´õ ¸¹Àº Áö¿ªÀÌ Ã·´Ü Áø´Ü µµ±¸¿Í Ä¡·á¹ýÀ» ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó È¿°úÀûÀ̰í ħ½ÀÀûÀÎ Áø´Ü ¹× Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í GI ³»½Ã°æ Àåºñ ¼ö¿ä´Â »ó½Â ±âÁ¶¸¦ °è¼ÓÇÒ ¶§ ¿¹»óµË´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÁÖ¸ñÀÇ 32»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Gastrointestinal (GI) Endoscopy Devices Market to Reach US$49.9 Billion by 2030

The global market for Gastrointestinal (GI) Endoscopy Devices estimated at US$35.2 Billion in the year 2023, is expected to reach US$49.9 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$25.5 Billion by the end of the analysis period. Growth in the Capsule Endoscopes segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.5 Billion While China is Forecast to Grow at 8.6% CAGR

The Gastrointestinal (GI) Endoscopy Devices market in the U.S. is estimated at US$9.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$10.9 Billion by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Gastrointestinal (GI) Endoscopy Devices Market - Key Trends and Drivers Summarized

Gastrointestinal (GI) endoscopy devices are critical in the medical field for diagnosing and treating various digestive system disorders. These devices encompass a broad spectrum of instruments, including flexible endoscopes, high-definition visualization systems, and an array of accessories such as biopsy forceps, polypectomy snares, and hemostatic devices. GI endoscopy facilitates minimally invasive examinations of the gastrointestinal tract, offering detailed, real-time imagery and videos of the esophagus, stomach, intestines, and colon. Recent technological advancements have significantly enhanced these devices, leading to the development of more sophisticated, flexible, and miniaturized endoscopes that improve diagnostic accuracy for conditions such as gastrointestinal cancers, ulcers, and inflammatory bowel diseases. Additionally, innovations like artificial intelligence (AI)-assisted image analysis, enhanced endoscope maneuverability, and improved imaging capabilities have revolutionized endoscopic procedures, making them more efficient and less invasive. These advancements have not only enhanced the diagnostic capabilities of GI endoscopy devices but have also improved patient comfort and outcomes.

The market for GI endoscopy devices is experiencing significant growth, driven by the increasing prevalence of gastrointestinal diseases and the growing adoption of early diagnostic techniques. Gastrointestinal disorders rank among the most common health issues globally, affecting millions of people and imposing substantial healthcare costs. The global aging population is particularly vulnerable to these conditions, resulting in a heightened demand for diagnostic and therapeutic endoscopic procedures. Additionally, there is a growing awareness and acceptance of minimally invasive surgeries among both patients and healthcare providers, which has accelerated the adoption of GI endoscopy devices. Healthcare facilities, including hospitals and clinics, are investing heavily in state-of-the-art endoscopic equipment to enhance patient care, improve diagnostic accuracy, and reduce hospitalization times. This trend is further supported by favorable reimbursement policies in many regions, which incentivize healthcare providers to expand their endoscopic services. As a result, there is a notable increase in the utilization of advanced GI endoscopy devices in clinical settings worldwide.

The growth in the GI endoscopy devices market is driven by several factors, including technological advancements, the rising incidence of gastrointestinal diseases, and the growing preference for minimally invasive procedures. Technological innovations have played a pivotal role, with the integration of artificial intelligence in endoscopic imaging significantly enhancing diagnostic accuracy and speed, allowing for more precise detection of abnormalities. The development of disposable endoscopes has also been a major advancement, reducing the risk of cross-contamination and infection, which has further boosted their adoption in clinical settings. The increasing prevalence of colorectal cancer and other gastrointestinal cancers has underscored the need for regular screenings, contributing significantly to market growth. Additionally, lifestyle changes, such as poor dietary habits and sedentary lifestyles, have led to a surge in gastrointestinal disorders, thereby driving demand for endoscopic procedures. Furthermore, the expansion of healthcare infrastructure in emerging markets and rising healthcare expenditures are creating new growth opportunities for the GI endoscopy devices market. As more regions gain access to advanced diagnostic tools and treatments, the demand for GI endoscopy devices is expected to continue its upward trajectory, driven by the need for effective, minimally invasive diagnostic and therapeutic solutions.

Select Competitors (Total 32 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â